{
    "organizations": [],
    "uuid": "a9b8621471803e229bcca570a85316839da341ea",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-nektar-therapeutics-q4-loss-per-sh/brief-nektar-therapeutics-q4-loss-per-share-0-21-idUSASB0C8H5",
    "ord_in_thread": 0,
    "title": "Nektar Therapeutics Q4 Loss Per Share $0.21",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - Nektar Therapeutics:\n* REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS\n* Q4 LOSS PER SHARE $0.21 * Q4 REVENUE $95.5 MILLION VERSUS $37.5 MILLION Source text for Eikon:\n ",
    "published": "2018-03-02T05:49:00.000+02:00",
    "crawled": "2018-03-02T20:01:01.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "nektar",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "q4",
        "revenue",
        "million",
        "versus",
        "million",
        "source",
        "text",
        "eikon"
    ]
}